HTG MOLECULAR DIAGNOSTICS, INC: Nasdaq/NYSE listing notice — HTG Molecular receives Nasdaq delisting notice for stockholders' equity below $2.5M

HTG MOLECULAR DIAGNOSTICS, INC

Nasdaq notified HTG Molecular on Nov 18, 2022 for non-compliance due to stockholders' equity falling below $2.5M as of Sept 30, 2022.
Company has 45 calendar days, until Jan 2, 2023, to submit a plan to regain compliance with Nasdaq Rule 5550(b).
If plan accepted, Nasdaq may grant up to 180-day extension from Notice date for evidence of compliance.
No assurance that the Company will be able to regain compliance with the continued listing standard.

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

HTG MOLECULAR DIAGNOSTICS, INC received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: stockholders equity
Rules: 5550(b)

Exact text from the filing

November 18, 2022, HTG Molecular Diagnostics, Inc. (the “Company”) received notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) that, as a result of the Company’s stockholders’ equity falling below $2.5 million, as reported in the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2022, the Company does not satisfy one of The Nasdaq Capital Market continued listing requirement set forth in Nasdaq Stock Market Rule 5550(b) (the “Rule”). Pursuant to the Notice and Nasdaq rules, the Company has 45 calendar days, or until January 2, 2023, to submit a plan to

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0000950170-22-025443

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.